PolyPeptide Group AG

Fr 40.05As of Sun 8 Nov 2026, 12:00 UTC
SWX:PPGNHealthcare
Country Switzerland
PE (Fwd) •••
TSR 6Y CAGR (11.76%)
Div yield —
ROE 4.24%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.04
PE TTM 97.95
TSR TTM 54.04%
Mkt cap Fr 1.322B
ROIC 5.75%
SE Grade™
Value
Quality
Moat
Consensus
Reference
Fr 46
15.70%
(96.63%)
Hold 0|3|3|10|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.79
0.85
0.86
0.93
26.68%
28.94%
18.87%
22.34%
Revenue€M
62.74
63.81
64.12
63.74
0.17%
3.71%
7.06%
6.17%
Peers (US$1.622B)
Cap (US$)
PE
3.868B
18.46x
109.2M
—
1.622B
23.44x
Capital
TTM
5Y
10Y
Leveragex
1.440
—
—
EBIT/Intx
2.242
0.578
0.546
Own earn%
51.65
(59.06)
(51.07)
Sh yield%
46.09
12.19
13.43
Owners
Insiders/Inst%
8.29
65.40
Short interest%
1.73
SBC / revenue%
5.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
2–8
$1 testx
0.0
Incr. ROIC%
9